Utilização de microesferas biodegradáveis PLGA como sistema de liberação para a vacina sintética SBm7462 no controle do Boophilus microplus (Canestrini, 1887): modelo experimental em camundongos

Detalhes bibliográficos
Autor(a) principal: Sales Junior, Policarpo Ademar
Data de Publicação: 2003
Tipo de documento: Dissertação
Idioma: por
Título da fonte: LOCUS Repositório Institucional da UFV
Texto Completo: http://locus.ufv.br/handle/123456789/5172
Resumo: Was evaluated the immunological response of synthetic peptide SBm7462 emulsified with the adjuvant saponin or encapsulated in biodegradable PLGA microspheres; as well as, the response of synthetic peptide SPf66 encapsulated on cited delivery system. Mice Balb/c, female, were utilized on study, with a dose of 100mg of peptide for each animal. The mice were separated in six groups of twenty: group I: animals inoculated with 75mg of saponin; group II: inoculated with 100mL of water milliQ; group III: immunized with the peptide SBm7462 emulsified on saponin, 75mg of saponin for 100mg of peptide; group IV: inoculated with empty microspheres; group V: immunized with the peptide SBm7462 enclausured in PLGA microspheres; group VI: immunized with the synthetic peptide SPf66 enclausured in PLGA microspheres. The three inoculations was executed on day zero and latter on third and sixth weeks after the first inoculation. The mice were bled prior of first immunisation and at periodic intervals (of seven days) until week 21. The serum was assayed by indirect ELISA for detection of specific IgGs anti-SBm7462, and for realization of tests of hepatic function. The synthetic peptide SBm7462 showed a better immune response emulsified with saponin adjuvant. The peptide SPf66 showed a similar response when compared with the obtained for others authors when encapsulated in PLGA microspheres and utilized in mice. The tests of hepatic function were realized in equipament multiparametric of bioquimic Alisé, and no evidence of hepatotoxic effects was viewed, when was evaluated the parameters: total proteins, albumin, AST and ALT. In order to verification of histologic alterations post-immunization, were colleted spleen of mice, for each treatment, on day zero, three, six and nine days post the second inoculation and two, four and six days post the third inoculation. The results obtained showed the saponin potentiate a better immune response of peptide SBm7462, and this response was more precoce than the obtained with the PLGA microspheres. This delivery system show itself as a good approach for utilization with the synthetic peptide SBm7462, nevertheless more studies are necessary for promotion of a better efficacy of encapsulation.
id UFV_40fbc3192d1a49f9d936bcca6e6d5b41
oai_identifier_str oai:locus.ufv.br:123456789/5172
network_acronym_str UFV
network_name_str LOCUS Repositório Institucional da UFV
repository_id_str 2145
spelling Sales Junior, Policarpo Ademarhttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4764903E9Salcedo, Joaquín Hernán Patarroyohttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4783313T4Viloria, Marlene Isabel Vargashttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4781964E6Guimarães, Antonio Marcoshttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4786353E2Afonso, Luis Carlos Croccohttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4789739U0Santos, Tomaz Aroldo da Motahttp://lattes.cnpq.br/22150793357716202015-03-26T13:47:21Z2007-07-202015-03-26T13:47:21Z2003-12-19SALES JUNIOR, Policarpo Ademar. Utilization of biodegradable PLGA microspheres as a delivery system for synthetic vaccine SBm7462 on control of the Boophilus microplus (Canestrini, 1887): experimental model in mice. 2003. 94 f. Dissertação (Mestrado em Biotecnologia, diagnóstico e controle de doenças; Epidemiologia e controle de qualidade de prod. de) - Universidade Federal de Viçosa, Viçosa, 2003.http://locus.ufv.br/handle/123456789/5172Was evaluated the immunological response of synthetic peptide SBm7462 emulsified with the adjuvant saponin or encapsulated in biodegradable PLGA microspheres; as well as, the response of synthetic peptide SPf66 encapsulated on cited delivery system. Mice Balb/c, female, were utilized on study, with a dose of 100mg of peptide for each animal. The mice were separated in six groups of twenty: group I: animals inoculated with 75mg of saponin; group II: inoculated with 100mL of water milliQ; group III: immunized with the peptide SBm7462 emulsified on saponin, 75mg of saponin for 100mg of peptide; group IV: inoculated with empty microspheres; group V: immunized with the peptide SBm7462 enclausured in PLGA microspheres; group VI: immunized with the synthetic peptide SPf66 enclausured in PLGA microspheres. The three inoculations was executed on day zero and latter on third and sixth weeks after the first inoculation. The mice were bled prior of first immunisation and at periodic intervals (of seven days) until week 21. The serum was assayed by indirect ELISA for detection of specific IgGs anti-SBm7462, and for realization of tests of hepatic function. The synthetic peptide SBm7462 showed a better immune response emulsified with saponin adjuvant. The peptide SPf66 showed a similar response when compared with the obtained for others authors when encapsulated in PLGA microspheres and utilized in mice. The tests of hepatic function were realized in equipament multiparametric of bioquimic Alisé, and no evidence of hepatotoxic effects was viewed, when was evaluated the parameters: total proteins, albumin, AST and ALT. In order to verification of histologic alterations post-immunization, were colleted spleen of mice, for each treatment, on day zero, three, six and nine days post the second inoculation and two, four and six days post the third inoculation. The results obtained showed the saponin potentiate a better immune response of peptide SBm7462, and this response was more precoce than the obtained with the PLGA microspheres. This delivery system show itself as a good approach for utilization with the synthetic peptide SBm7462, nevertheless more studies are necessary for promotion of a better efficacy of encapsulation.Foi avaliada a resposta imunológica do peptídeo sintético SBm7462 emulsificado com o adjuvante saponina ou encapsulado em microesferas biodegradáveis PLGA; bem como, a do peptídeo sintético SPf66 encapsulado no referido sistema de liberação. O estudo foi realizado com camundongos Balb/c, fêmeas, utilizando-se uma dose de 100 mg de peptídeo por animal. Os camundongos foram separados em seis grupos de vinte: grupo I: animais em que foram inoculados 75mg de saponina; grupo II: inoculados com 100 mL de água milli Q; grupo III: imunizados com o peptídeo SBm7462 emulsificado com o adjuvante saponina (75mg de saponina para 100mg de peptídeo); grupo IV: inoculados com as microesferas vazias; grupo V: imunizados com o peptídeo SBm7462 encapsulado nas microesferas PLGA; grupo VI: imunizados com o peptídeo sintético SPf66 encapsulado nas microesferas PLGA. As três inoculações foram efetuadas no dia zero e depois a cada três semanas. Os camundongos foram sangrados antes da primeira imunização e a intervalos periódicos (a cada sete dias) até 21ª semana, sendo o soro utilizado para a realização de ELISA indireto para detecção de IgGs anti-SBm7462, como também para a realização de testes de função hepática. O peptídeo sintético SBm7462 mostrou uma melhor resposta humoral quando emulsificado com o adjuvante saponina. Já o SPf66 mostrou uma resposta similar à encontrada por outros autores quando encapsulado em microesferas PLGA e utilizado em camundongos. Os testes de função hepática foram realizados em equipamento multiparamétrico de bioquímica Alisé e, não se observou evidências de efeitos hepatotóxicos quando foram avaliados parâmetros como proteínas totais, albumina, AST e ALT. Foram também coletados baços de camundongos para verificação das alterações histológicas pós-imunização, para cada tratamento, no dia zero, três, seis e nove dias após a segunda e dois, quatro e seis dias após a terceira inoculação. Os resultados obtidos revelam que a saponina potencializa uma melhor resposta imune do peptídeo SBm7462, tendo sido também esta resposta mais precoce e que, as microesferas PLGA mostram-se viáveis a serem utilizadas como sistema de liberação para este peptídeo, necessitando-se, porém, de estudos adicionais para promoção de uma melhor eficácia de encapsulação.Fundação Oswaldo Cruzapplication/pdfporUniversidade Federal de ViçosaMestrado em Medicina VeterináriaUFVBRBiotecnologia, diagnóstico e controle de doenças; Epidemiologia e controle de qualidade de prod. deBoophilus microplusVacina sintéticaAdjuvantesBoophilus microplusSynthetic vaccineAdjuvantsCNPQ::CIENCIAS AGRARIAS::MEDICINA VETERINARIA::MEDICINA VETERINARIA PREVENTIVAUtilização de microesferas biodegradáveis PLGA como sistema de liberação para a vacina sintética SBm7462 no controle do Boophilus microplus (Canestrini, 1887): modelo experimental em camundongosUtilization of biodegradable PLGA microspheres as a delivery system for synthetic vaccine SBm7462 on control of the Boophilus microplus (Canestrini, 1887): experimental model in miceinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/openAccessreponame:LOCUS Repositório Institucional da UFVinstname:Universidade Federal de Viçosa (UFV)instacron:UFVORIGINALtexto completo.pdfapplication/pdf876611https://locus.ufv.br//bitstream/123456789/5172/1/texto%20completo.pdfa2f759bb57143bd8beafaa8f6d9a9652MD51TEXTtexto completo.pdf.txttexto completo.pdf.txtExtracted texttext/plain142942https://locus.ufv.br//bitstream/123456789/5172/2/texto%20completo.pdf.txt2ecb80247bfe636965357ffe0cc78296MD52THUMBNAILtexto completo.pdf.jpgtexto completo.pdf.jpgIM Thumbnailimage/jpeg3661https://locus.ufv.br//bitstream/123456789/5172/3/texto%20completo.pdf.jpg0a07fdbdace2f0081f39098b52dd1dcfMD53123456789/51722016-04-11 23:09:44.922oai:locus.ufv.br:123456789/5172Repositório InstitucionalPUBhttps://www.locus.ufv.br/oai/requestfabiojreis@ufv.bropendoar:21452016-04-12T02:09:44LOCUS Repositório Institucional da UFV - Universidade Federal de Viçosa (UFV)false
dc.title.por.fl_str_mv Utilização de microesferas biodegradáveis PLGA como sistema de liberação para a vacina sintética SBm7462 no controle do Boophilus microplus (Canestrini, 1887): modelo experimental em camundongos
dc.title.alternative.eng.fl_str_mv Utilization of biodegradable PLGA microspheres as a delivery system for synthetic vaccine SBm7462 on control of the Boophilus microplus (Canestrini, 1887): experimental model in mice
title Utilização de microesferas biodegradáveis PLGA como sistema de liberação para a vacina sintética SBm7462 no controle do Boophilus microplus (Canestrini, 1887): modelo experimental em camundongos
spellingShingle Utilização de microesferas biodegradáveis PLGA como sistema de liberação para a vacina sintética SBm7462 no controle do Boophilus microplus (Canestrini, 1887): modelo experimental em camundongos
Sales Junior, Policarpo Ademar
Boophilus microplus
Vacina sintética
Adjuvantes
Boophilus microplus
Synthetic vaccine
Adjuvants
CNPQ::CIENCIAS AGRARIAS::MEDICINA VETERINARIA::MEDICINA VETERINARIA PREVENTIVA
title_short Utilização de microesferas biodegradáveis PLGA como sistema de liberação para a vacina sintética SBm7462 no controle do Boophilus microplus (Canestrini, 1887): modelo experimental em camundongos
title_full Utilização de microesferas biodegradáveis PLGA como sistema de liberação para a vacina sintética SBm7462 no controle do Boophilus microplus (Canestrini, 1887): modelo experimental em camundongos
title_fullStr Utilização de microesferas biodegradáveis PLGA como sistema de liberação para a vacina sintética SBm7462 no controle do Boophilus microplus (Canestrini, 1887): modelo experimental em camundongos
title_full_unstemmed Utilização de microesferas biodegradáveis PLGA como sistema de liberação para a vacina sintética SBm7462 no controle do Boophilus microplus (Canestrini, 1887): modelo experimental em camundongos
title_sort Utilização de microesferas biodegradáveis PLGA como sistema de liberação para a vacina sintética SBm7462 no controle do Boophilus microplus (Canestrini, 1887): modelo experimental em camundongos
author Sales Junior, Policarpo Ademar
author_facet Sales Junior, Policarpo Ademar
author_role author
dc.contributor.authorLattes.por.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4764903E9
dc.contributor.author.fl_str_mv Sales Junior, Policarpo Ademar
dc.contributor.advisor1.fl_str_mv Salcedo, Joaquín Hernán Patarroyo
dc.contributor.advisor1Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4783313T4
dc.contributor.referee1.fl_str_mv Viloria, Marlene Isabel Vargas
dc.contributor.referee1Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4781964E6
dc.contributor.referee2.fl_str_mv Guimarães, Antonio Marcos
dc.contributor.referee2Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4786353E2
dc.contributor.referee3.fl_str_mv Afonso, Luis Carlos Crocco
dc.contributor.referee3Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4789739U0
dc.contributor.referee4.fl_str_mv Santos, Tomaz Aroldo da Mota
dc.contributor.referee4Lattes.fl_str_mv http://lattes.cnpq.br/2215079335771620
contributor_str_mv Salcedo, Joaquín Hernán Patarroyo
Viloria, Marlene Isabel Vargas
Guimarães, Antonio Marcos
Afonso, Luis Carlos Crocco
Santos, Tomaz Aroldo da Mota
dc.subject.por.fl_str_mv Boophilus microplus
Vacina sintética
Adjuvantes
topic Boophilus microplus
Vacina sintética
Adjuvantes
Boophilus microplus
Synthetic vaccine
Adjuvants
CNPQ::CIENCIAS AGRARIAS::MEDICINA VETERINARIA::MEDICINA VETERINARIA PREVENTIVA
dc.subject.eng.fl_str_mv Boophilus microplus
Synthetic vaccine
Adjuvants
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS AGRARIAS::MEDICINA VETERINARIA::MEDICINA VETERINARIA PREVENTIVA
description Was evaluated the immunological response of synthetic peptide SBm7462 emulsified with the adjuvant saponin or encapsulated in biodegradable PLGA microspheres; as well as, the response of synthetic peptide SPf66 encapsulated on cited delivery system. Mice Balb/c, female, were utilized on study, with a dose of 100mg of peptide for each animal. The mice were separated in six groups of twenty: group I: animals inoculated with 75mg of saponin; group II: inoculated with 100mL of water milliQ; group III: immunized with the peptide SBm7462 emulsified on saponin, 75mg of saponin for 100mg of peptide; group IV: inoculated with empty microspheres; group V: immunized with the peptide SBm7462 enclausured in PLGA microspheres; group VI: immunized with the synthetic peptide SPf66 enclausured in PLGA microspheres. The three inoculations was executed on day zero and latter on third and sixth weeks after the first inoculation. The mice were bled prior of first immunisation and at periodic intervals (of seven days) until week 21. The serum was assayed by indirect ELISA for detection of specific IgGs anti-SBm7462, and for realization of tests of hepatic function. The synthetic peptide SBm7462 showed a better immune response emulsified with saponin adjuvant. The peptide SPf66 showed a similar response when compared with the obtained for others authors when encapsulated in PLGA microspheres and utilized in mice. The tests of hepatic function were realized in equipament multiparametric of bioquimic Alisé, and no evidence of hepatotoxic effects was viewed, when was evaluated the parameters: total proteins, albumin, AST and ALT. In order to verification of histologic alterations post-immunization, were colleted spleen of mice, for each treatment, on day zero, three, six and nine days post the second inoculation and two, four and six days post the third inoculation. The results obtained showed the saponin potentiate a better immune response of peptide SBm7462, and this response was more precoce than the obtained with the PLGA microspheres. This delivery system show itself as a good approach for utilization with the synthetic peptide SBm7462, nevertheless more studies are necessary for promotion of a better efficacy of encapsulation.
publishDate 2003
dc.date.issued.fl_str_mv 2003-12-19
dc.date.available.fl_str_mv 2007-07-20
2015-03-26T13:47:21Z
dc.date.accessioned.fl_str_mv 2015-03-26T13:47:21Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv SALES JUNIOR, Policarpo Ademar. Utilization of biodegradable PLGA microspheres as a delivery system for synthetic vaccine SBm7462 on control of the Boophilus microplus (Canestrini, 1887): experimental model in mice. 2003. 94 f. Dissertação (Mestrado em Biotecnologia, diagnóstico e controle de doenças; Epidemiologia e controle de qualidade de prod. de) - Universidade Federal de Viçosa, Viçosa, 2003.
dc.identifier.uri.fl_str_mv http://locus.ufv.br/handle/123456789/5172
identifier_str_mv SALES JUNIOR, Policarpo Ademar. Utilization of biodegradable PLGA microspheres as a delivery system for synthetic vaccine SBm7462 on control of the Boophilus microplus (Canestrini, 1887): experimental model in mice. 2003. 94 f. Dissertação (Mestrado em Biotecnologia, diagnóstico e controle de doenças; Epidemiologia e controle de qualidade de prod. de) - Universidade Federal de Viçosa, Viçosa, 2003.
url http://locus.ufv.br/handle/123456789/5172
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Viçosa
dc.publisher.program.fl_str_mv Mestrado em Medicina Veterinária
dc.publisher.initials.fl_str_mv UFV
dc.publisher.country.fl_str_mv BR
dc.publisher.department.fl_str_mv Biotecnologia, diagnóstico e controle de doenças; Epidemiologia e controle de qualidade de prod. de
publisher.none.fl_str_mv Universidade Federal de Viçosa
dc.source.none.fl_str_mv reponame:LOCUS Repositório Institucional da UFV
instname:Universidade Federal de Viçosa (UFV)
instacron:UFV
instname_str Universidade Federal de Viçosa (UFV)
instacron_str UFV
institution UFV
reponame_str LOCUS Repositório Institucional da UFV
collection LOCUS Repositório Institucional da UFV
bitstream.url.fl_str_mv https://locus.ufv.br//bitstream/123456789/5172/1/texto%20completo.pdf
https://locus.ufv.br//bitstream/123456789/5172/2/texto%20completo.pdf.txt
https://locus.ufv.br//bitstream/123456789/5172/3/texto%20completo.pdf.jpg
bitstream.checksum.fl_str_mv a2f759bb57143bd8beafaa8f6d9a9652
2ecb80247bfe636965357ffe0cc78296
0a07fdbdace2f0081f39098b52dd1dcf
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv LOCUS Repositório Institucional da UFV - Universidade Federal de Viçosa (UFV)
repository.mail.fl_str_mv fabiojreis@ufv.br
_version_ 1801212892949774336